Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada

Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada

Background and Objectives Neoadjuvant chemoradiation and liver transplantation may be offered for unresectable perihilar cholangiocarcinoma (pCCA). This study aimed to determine the dropout rate and survival of patients who entered a national tri‐modality protocol. Method Patients enrolled Jan 2009‐...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of surgical oncology 2018-02, Vol.117 (2), p.213-219
Hauptverfasser: Loveday, Benjamin P.T., Knox, Jennifer J., Dawson, Laura A., Metser, Ur, Brade, Anthony, Horgan, Anne M., Gallinger, Steven, Greig, Paul D., Moulton, Carol‐anne
Format: Artikel
Sprache:eng
Schlagworte:
antineoplastic agents
Cancer surgery
cholangiocarcinoma
liver transplantation
Liver transplants
radiotherapy
School dropouts
Transplants & implants
treatment outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Objectives Neoadjuvant chemoradiation and liver transplantation may be offered for unresectable perihilar cholangiocarcinoma (pCCA). This study aimed to determine the dropout rate and survival of patients who entered a national tri‐modality protocol. Method Patients enrolled Jan 2009‐Aug 2015 were included. Enrolment criteria: ≤65 years, brush biopsy‐proven unresectable pCCA
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.24833